Newly elected French president Emmanuel Macron did not talk much about healthcare during his campaign. Now that his party has won a sweeping majority in Parliament, what is in store for the sector?
Spain may have turned its back on the Alzira model, but its creator Ribera Salud is looking for accountable care management contracts in the UK, we heard this week.
The UK government’s private equity arm has told Healthcare Nova it’s undertaking due diligence on one Indian healthcare group, and another healthcare group elsewhere in Asia.
New regulations about holding data are coming into force on May 28, 2018, across Europe – and breaching them could prove costly. Healthcare Europa speaks to John Gladstone, EMEA healthcare practice lead at data protection company Commvault, about how this legislation could be a blessing in disguise.
A session at Healthcare Asia on market trends and opportunities in SE Asia brought together three of the largest hospital groups in SE Asia – Siloam in Indonesia, Metro Pacific in The Philippines and KPJ in Malaysia. So how do they see the world and what strategies are they adopting?
Expect more STPs (Sustainability and Transformation Plans), more self-pay and more salaried hospital doctors in the UK. That’s according to several speakers at the Private Healthcare Summit in London.
GCC governments are doing everything they can to keep patients at home. It's working: between 2014 and 2016, private hospitals in the USA, the UK and Germany have all seen a drop in the number of medical tourists from the region - with Germany experiencing a fall of nearly 60%. Graham Elderfield, founder of consultancy Glenfield Consulting, explained why at the Private Healthcare Summit 2017 in London.
Healthquad, an Indian specialist healthcare VC fund has achieved its final close with a total commitment of Rs. 750 million (approximately USD 11.72m) for investing in “thematic and disruptive” healthcare business models in the country.
The private equity owners of Finland's largest healthcare group Mehilainen have tasked JP Morgan with testing the M&A waters, but a public listing in Helsinki remains the most likely outcome.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
